The diagnostic and prognosis accuracy of lung cancer can be improved by incorporating miR-17-5p with conventional tumour markers including CEA (Carcinoembryonic Antigen), CYFRA21-1 (Cytokeratin 19 Fragment), and SCCA (Squamous Cell Carcinoma Antigen). The gene discussed is CEACAM5; the disease is neoplasm.